Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Strong earnings suggest Allergan sold too cheap, analyst says
Strong earnings suggest Allergan sold too cheap, analyst says
Strong earnings suggest Allergan sold too cheap, analyst says
Submitted by
admin
on February 6, 2015 - 10:26am
Source:
Fierce Pharma
News Tags:
Allergan
earnings
M&A
Actavis
Headline:
Strong earnings suggest Allergan sold too cheap, analyst says
Do Not Allow Advertisers to Use My Personal information
